NDC codes

FDA NDC Directory
Product NDC (as listed)29300-239Labeler and product segments. Claims need a package NDC.
Product NDC at billing width29300-0239Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
29300-239-0529300023905500 TABLET in 1 BOTTLE, PLASTIC (29300-239-05)Marketed from Aug 5, 2020
29300-239-162930002391660 TABLET in 1 BOTTLE, PLASTIC (29300-239-16)Marketed from Aug 5, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Tolterodine Tartrate
Generic name (nonproprietary)
tolterodine tartrate
Active ingredients
Tolterodine tartrate — 1 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 205399
Marketing start
Listing expires
Other FDA classes
Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers
Product ID 29300-239_9faf1be0-1f13-47c0-b2aa-3ad62e5037e9SPL ID 9faf1be0-1f13-47c0-b2aa-3ad62e5037e9SPL set ID 56e62829-5371-416a-90b3-4b6429532d25RxCUI 855178, 855194UNII 5T619TQR3R
Pharmacologic class
Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N429300023905 followed by a unit qualifier and the quantity

Package 29300-0239-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205399

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205399
ProductStrengthForm · routeLabelerProduct NDC
Tolterodine TartrateTolterodine tartrate 2 mg/1TabletOralUnichem Pharmaceuticals (USA), Inc.29300-240

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in